UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells

Cancer research (Chicago, Ill.), 2011-08, Vol.71 (15), p.5296-5306

2011

Link zum Volltext

Verfügbarkeit prüfen

Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment

Future oncology (London, England), 2012-06, Vol.8 (6), p.713-722

2012

Link zum Volltext

Verfügbarkeit prüfen

WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition

Cancer research (Chicago, Ill.), 2014-05, Vol.74 (9), p.2510-2519

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

Clinical cancer research, 2017-11, Vol.23 (22), p.6833-6845

2017

Link zum Volltext

Verfügbarkeit prüfen

Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer

Cell reports (Cambridge), 2017-10, Vol.21 (2), p.495-507

2017

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (7), p.1945-1957

2014

Link zum Volltext

Verfügbarkeit prüfen

Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy

Cancers, 2021-02, Vol.13 (5), p.968

2021

Link zum Volltext

Verfügbarkeit prüfen

Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack

Frontiers in oncology, 2018-05, Vol.8, p.143-143

2018

Link zum Volltext

Verfügbarkeit prüfen

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

Journal for immunotherapy of cancer, 2023-09, Vol.11 (9), p.e007386

2023

Link zum Volltext

Verfügbarkeit prüfen

The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance

Vaccines (Basel), 2016-06, Vol.4 (3), p.22

2016

Link zum Volltext

Verfügbarkeit prüfen

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

Cancer Immunology, Immunotherapy, 2023-10, Vol.72 (10), p.3349-3362

2023

Link zum Volltext

Verfügbarkeit prüfen

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells

The Journal of clinical investigation, 2010-02, Vol.120 (2), p.533-544

2010

Link zum Volltext

Verfügbarkeit prüfen

Combination therapies utilizing neoepitope-targeted vaccines

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.875-885

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002605

2021

Link zum Volltext

Verfügbarkeit prüfen

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.350-368

2023

Link zum Volltext

Verfügbarkeit prüfen

MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition

Oncoimmunology, 2016-04, Vol.5 (4), p.e1117738-e1117738

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer

Clinical cancer research, 2016-12, Vol.22 (24), p.6204-6216

2016

Link zum Volltext

Verfügbarkeit prüfen

Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer

Endocrine-related cancer, 2016-10, Vol.23 (10), p.783-796

2016

Link zum Volltext

Verfügbarkeit prüfen

Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

Clinical cancer research, 2020-02, Vol.26 (3), p.704-716

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition

Cells, tissues, organs, 2017-01, Vol.203 (2), p.128-138

2017

Link zum Volltext

Verfügbarkeit prüfen

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

Oncotarget, 2016-07, Vol.7 (27), p.42031-42044

2016

Link zum Volltext

Verfügbarkeit prüfen

Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines

Advances in cancer research, 2015, Vol.128, p.69-93

2015

Link zum Volltext

Verfügbarkeit prüfen

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype

Molecular cancer therapeutics, 2013-09, Vol.12 (9), p.1805-1815

2013

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis

JNCI : Journal of the National Cancer Institute, 2014-05, Vol.106 (5), p.1

2014

Link zum Volltext

Verfügbarkeit prüfen

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Cancer Immunology, Immunotherapy, 2023-08, Vol.72 (8), p.2783-2797

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(88)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells

Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment

WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition

Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer

Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process

Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy

Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells

Combination therapies utilizing neoepitope-targeted vaccines

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC

MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition

Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer

Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer

Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy

Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib

Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype

Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Suchergebnisse filtern